Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
ZymoGenetics: 25 Years Young: An Interview with Bruce Carter, President and CEO




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: ZymoGenetics: 25 Years Young: An Interview with Bruce Carter, President and CEO
Released on: July 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton, CEO of PharmaVentures, talks exclusively to Bruce Carter, President and CEO of ZymoGenetics, a company that celebrated its 25th anniversary on 22 June 2006.
  • Summary
  • Transcript
  • Participants
  • Company
Fintan Walton, CEO of PharmaVentures, talks exclusively to Bruce Carter, President and CEO of ZymoGenetics, a company that celebrated its 25th anniversary on 22 June 2006. Bruce discusses a number of aspects of ZymoGenetics' operations, including its relationship with previous owners Novo Nordisk, its alliance with Serono and its drug development model. Bruce also shares his views and advice on biotech acquisitions and the key characteristics of a successful biotech CEO.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dr Bruce Carter joined ZymoGenetics in 1986 as Vice President of Research and Development. After a period as Corporate Executive Vice President and Chief Scientific Officer with Novo Nordisk A/S, Bruce became CEO of ZymoGenetics in April 1998. Earlier in his career, he worked at G.D. Searle & Co and was a Lecturer at Trinity College, University of Dublin.
ZymoGenetics